Evidence map›Paper›PMID 30350425›Full record

ArticleThe Journal of pathology2019

Increased dynamin expression precedes proteinuria in glomerular disease.

Ramzi Khalil, Klaas Koop, Reinhold Kreutz, Herman P Spaink, Pancras Cw Hogendoorn, Jan A Bruijn, Hans J Baelde

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Indirect podocyte injury manifested in a partial podocytectomy mouse model.American journal of physiology. Renal physiology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ramzi KhalilDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-7251-026X
Klaas KoopDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Reinhold KreutzInstitute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Herman P SpainkInstitute of Biology Leiden, Leiden University, Leiden, The Netherlands.
Pancras Cw HogendoornDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Jan A BruijnDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Hans J BaeldeDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NLHumboldt-Universität zu Berlin · DELeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamin plays an essential role in maintaining the structure and function of the glomerular filtration barrier. Specifically, dynamin regulates the actin cytoskeleton and the turnover of nephrin in podocytes, and knocking down dynamin expression causes proteinuria. Moreover, promoting dynamin oligomerization with Bis-T-23 restores podocyte function and reduces proteinuria in several animal models of chronic kidney disease. Thus, dynamin is a promising therapeutic target for treating chronic kidney disease. Here, we investigated the pathophysiological role of dynamin under proteinuric circumstances in a rat model and in humans. We found that glomerular Dnm2 and Dnm1 mRNA levels are increased prior to the onset of proteinuria in a rat model of spontaneous proteinuria. Also, in zebrafish embryos, we confirm that knocking down dynamin translation results in proteinuria. Finally, we show that the glomerular expression of dynamin and cathepsin L protein is increased in several human proteinuric kidney diseases. We propose that the increased expression of glomerular dynamin reflects an exhausted attempt to maintain and/or restore integrity of the glomerular filtration barrier. These results confirm that dynamin plays an important role in maintaining the glomerular filtration barrier, and they support the notion that dynamin is a promising therapeutic target in proteinuric kidney disease. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Indexed as

AdultAgedAnimalsCathepsin LDisease Models, AnimalDynamin IDynamin IIFemaleGlomerular Filtration RateHumansKidney DiseasesKidney GlomerulusMaleMiddle AgedProteinuriaRats, Inbred DahlCathepsin LCTSL protein, humanCtsl protein, ratDNM2 protein, humanDynamin IDynamin IIZebrafish Proteinsdynaminhistologykidney glomerulusproteinuriaratszebrafish

Identifiers

PMID30350425
PMCPMC6587474
OpenAlexW2896717782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.